Insiders · Profile

Sun Nelson

See Remarks at Aardvark Therapeutics. Filing since 14 Feb 2025. CIK 0002045377

Company

Date

Role

Action

Amount

Of holding

11 Sep 2026

See Remarks

Sold on a plan

62,000

$321.18K

63.6%

10 Sep 2026

See Remarks

Sold on a plan

14,754

$73.78K

13.1%

11 Dec 2025

Chief Financial Officer

Bought

3,000

$43.20K

2.8%

9 Sep 2025

Chief Financial Officer

Bought

6,000

$48.44K

6.0%

14 Feb 2025

Chief Financial Officer

Bought

10,000

$160.00K

11.2%

5 decisions on file.